Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Genes Dev. 2010 Feb 1;24(3):241-55. doi: 10.1101/gad.1874010. Epub 2010 Jan 15.
Innate immune cells can constitute a substantial proportion of the cells within the tumor microenvironment and have been associated with tumor malignancy in patients and animal models of cancer; however, the mechanisms by which they modulate cancer progression are incompletely understood. Here, we show that high levels of cathepsin protease activity are induced in the majority of macrophages in the microenvironment of pancreatic islet cancers, mammary tumors, and lung metastases during malignant progression. We further show that tumor-associated macrophage (TAM)-supplied cathepsins B and S are critical for promoting pancreatic tumor growth, angiogenesis, and invasion in vivo, and markedly enhance the invasiveness of cancer cells in culture. Finally, we demonstrate that interleukin-4 (IL-4) is responsible for inducing cathepsin activity in macrophages in vitro and in vivo. Together, these data establish IL-4 as an important regulator, and cathepsin proteases as critical mediators, of the cancer-promoting functions of TAMs.
先天免疫细胞可以构成肿瘤微环境中细胞的很大一部分,并且与患者和癌症动物模型中的肿瘤恶性程度有关;然而,它们调节癌症进展的机制尚不完全清楚。在这里,我们表明在胰岛癌、乳腺癌和肺转移的微环境中,大多数巨噬细胞中诱导了高水平的组织蛋白酶蛋白酶活性,在恶性进展过程中。我们进一步表明,肿瘤相关巨噬细胞(TAM)提供的组织蛋白酶 B 和 S 对于促进体内胰腺肿瘤生长、血管生成和浸润至关重要,并显著增强培养的癌细胞的侵袭性。最后,我们证明白细胞介素 4(IL-4)负责体外和体内诱导巨噬细胞中的组织蛋白酶活性。总之,这些数据确立了白细胞介素 4 作为 TAM 促进癌症功能的重要调节剂和组织蛋白酶蛋白酶作为关键介质。